To confirm these findings, we conducted an experiment with MDA-MB231 human breast cancer cells transiently overexpressing the two different VDR variants under identical conditions and found similar results (VDRff treatment vs VDRFF treatment, P<0.01; Figure 3C). This evidence concerns the gene VDR and breast carcinoma.